title: Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.
abstract: BACKGROUND
  Psychotropic medications are commonly used for depressive symptoms among people living with HIV/AIDS.
  
  
  OBJECTIVE
  We examined the relationships between adherence to psychotropic medications, depressive symptoms, and antiretroviral adherence.
  
  
  METHODS
  We assessed depressive symptoms among 324 people living with HIV/AIDS across a 3-month period (70% men; mean age 45 years; 90% African-American). Psychotropic and antiretroviral adherence was assessed using monthly, unannounced telephone pill counts. Multiple-regression and mediation analyses were utilized to examine associations under investigation.
  
  
  RESULTS
  Greater depressive symptoms were associated with lower antiretroviral and psychotropic medication adherence. Greater adherence to psychotropic medications regardless of medication class was positively related to higher antiretroviral adherence. Greater adherence to psychotropic medications also significantly mediated the association between depressive symptoms and antiretroviral adherence.
  
  
  CONCLUSIONS
  This study demonstrates the benefits of adherence to psychotropic medications on both depressive symptoms and antiretroviral adherence. Future work examining psychotropic medication adherence on disease outcomes in people living with HIV/AIDS is warranted.
authors.affiliation: Department of Psychology, University of Connecticut, Storrs, USA. Dean.Cruess@uconn.edu
authors.forename: Dean G
authors.initials: DG
authors.lastname: Cruess
authors.forename: Seth C
authors.initials: SC
authors.lastname: Kalichman
authors.forename: Christine
authors.initials: C
authors.lastname: Amaral
authors.forename: Connie
authors.initials: C
authors.lastname: Swetzes
authors.forename: Chauncey
authors.initials: C
authors.lastname: Cherry
authors.forename: Moira O
authors.initials: MO
authors.lastname: Kalichman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000523:psychology*; D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000523:psychology*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D001523:Mental Disorders / Q000188:drug therapy* / Q000523:psychology; D008875:Middle Aged
chemical_list: D044966:Anti-Retroviral Agents; D000928:Antidepressive Agents
references.citation: Arch Gen Psychiatry. 2001 Aug;58(8):729-36
references.pmid: 11483138
references.citation: Biol Psychiatry. 2003 Aug 1;54(3):295-306
references.pmid: 12893105
references.citation: J Acquir Immune Defic Syndr. 2010 Jun;54(2):197-203
references.pmid: 20035231
references.citation: J Acquir Immune Defic Syndr. 2010 Feb;53(2):266-72
references.pmid: 20104122
references.citation: J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):445-8
references.pmid: 15764962
references.citation: Ann Intern Med. 2001 Jul 3;135(1):17-26
references.pmid: 11434728
references.citation: Lancet. 2002 Jul 13;360(9327):119-29
references.pmid: 12126821
references.citation: J Clin Psychopharmacol. 2007 Feb;27(1):58-61
references.pmid: 17224714
references.citation: Am J Prev Med. 1994 Mar-Apr;10(2):77-84
references.pmid: 8037935
references.citation: Arch Gen Psychiatry. 2001 Aug;58(8):721-8
references.pmid: 11483137
references.citation: Clin Infect Dis. 2006 Oct 1;43(7):939-41
references.pmid: 16941380
references.citation: JAMA. 2001 Nov 28;286(20):2568-77
references.pmid: 11722271
references.citation: AIDS Patient Care STDS. 2005 Dec;19(12):813-22
references.pmid: 16375613
references.citation: N Engl J Med. 1997 Sep 11;337(11):725-33
references.pmid: 9287227
references.citation: JAMA. 2001 Mar 21;285(11):1466-74
references.pmid: 11255423
references.citation: Am J Psychiatry. 2002 May;159(5):789-96
references.pmid: 11986133
references.citation: J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S64-71
references.pmid: 18089986
references.citation: Arch Gen Psychiatry. 1988 Sep;45(9):859-64
references.pmid: 3415427
references.citation: Am J Psychiatry. 2002 Oct;159(10):1752-9
references.pmid: 12359683
references.citation: J Gen Intern Med. 2000 May;15(5):311-20
references.pmid: 10840266
references.citation: Am J Epidemiol. 2005 Jun 1;161(11):999-1012
references.pmid: 15901620
references.citation: Am J Psychiatry. 2005 Nov;162(11):2125-30
references.pmid: 16263853
references.citation: Subst Use Misuse. 2000 May-Jun;35(6-8):869-90
references.pmid: 10847215
references.citation: JAMA. 1998 Nov 4;280(17):1497-503
references.pmid: 9809730
references.citation: J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):384-90
references.pmid: 18091609
references.citation: AIDS Behav. 2006 May;10(3):227-45
references.pmid: 16783535
references.citation: Arch Gen Psychiatry. 1991 Feb;48(2):124-30
references.pmid: 1671198
references.citation: AIDS Patient Care STDS. 2009 Nov;23(11):903-14
references.pmid: 19642921
references.citation: AIDS Care. 2009 Aug;21(8):976-83
references.pmid: 20024753
references.citation: Psychiatr Q. 2009 Sep;80(3):131-41
references.pmid: 19387832
references.citation: HIV Clin Trials. 2008 Sep-Oct;9(5):298-308
references.pmid: 18977718
references.citation: Psychiatr Q. 2008 Mar;79(1):43-53
references.pmid: 18095166
references.citation: J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S136-9
references.pmid: 12562037
references.citation: J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):432-8
references.pmid: 15764960
references.citation: JAMA. 1993 Dec 1;270(21):2568-73
references.pmid: 7901433
references.citation: Biol Psychiatry. 2003 Aug 1;54(3):307-16
references.pmid: 12893106